Prophylactic treatment with oral azithromycin in patients with cancer during the COVID-19 pandemic: a randomized, single-blind, placebo-controlled phase 2 trial

Mair, M. J.; Maj-Hes, A.; Nussbaumer-Proll, A.; Puhr, R.; Christenheit, A.; Troch, M.; Puhr, H. C.; Starzer, A. M.; Steindl, A.; Eberl, S.; Haslacher, H.; Perkmann, T.; Minichsdorfer, C.; Prager, G. W.; Lamm, W. W.; Berghoff, A. S.; Kiesewetter, B.; Zeitlinger, M.; Preusser, M.; Raderer, M.

Mair, M. J.; Maj-Hes, A.; Nussbaumer-Proll, A.; Puhr, R.; Christenheit, A.; Troch, M.; Puhr, H. C.; Starzer, A. M.; Steindl, A.; Eberl, S.; Haslacher, H.; Perkmann, T.; Minichsdorfer, C.; Prager, G. W.; Lamm, W. W.; Berghoff, A. S.; Kiesewetter, B.; Zeitlinger, M.; Preusser, M.; Raderer, M..

Oncology Research and Treatment ; 45(SUPPL 2):131-131, 2022.

Article in English | Web of Science | ID: covidwho-2102245

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies / Randomized controlled trials Language: English Journal: Oncology Research and Treatment Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML